John H. Bond

Active 1970–2021

50
Papers
34,035
Citations
47
h-index
50
i10-index

Citations

Citations per year for John H. Bond1943: 3 citations1975: 1 citations1976: 2 citations1977: 6 citations1978: 5 citations1979: 6 citations1980: 5 citations1981: 15 citations1982: 16 citations1983: 12 citations1984: 12 citations1985: 15 citations1986: 18 citations1987: 18 citations1988: 26 citations1989: 3 citations1990: 12 citations1991: 11 citations1992: 14 citations1993: 22 citations1994: 27 citations1995: 51 citations1996: 57 citations1997: 78 citations1998: 62 citations1999: 76 citations2000: 125 citations2001: 135 citations2002: 183 citations2003: 197 citations2004: 266 citations2005: 232 citations2006: 253 citations2007: 228 citations2008: 357 citations2009: 345 citations2010: 359 citations2011: 276 citations2012: 348 citations2013: 347 citations2014: 316 citations2015: 285 citations2016: 219 citations2017: 195 citations2018: 133 citations2019: 598 citations2020: 470 citations2021: 388 citations2022: 287 citations2023: 169 citations2024: 285 citations2025: 115 citations2026: 8 citations1944–1974: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,425 citing papers, 34.8% of this breakdownUnited Kingdom: 528 citing papers, 7.6% of this breakdownChina: 380 citing papers, 5.4% of this breakdownJapan: 323 citing papers, 4.6% of this breakdownGermany: 273 citing papers, 3.9% of this breakdownNetherlands: 269 citing papers, 3.9% of this breakdownItaly: 255 citing papers, 3.7% of this breakdownCanada: 249 citing papers, 3.6% of this breakdownAustralia: 220 citing papers, 3.1% of this breakdownFrance: 180 citing papers, 2.6% of this breakdownSpain: 179 citing papers, 2.6% of this breakdownSouth Korea: 150 citing papers, 2.1% of this breakdown
0%34.8%Other 22.1%

Fields

  • Medicine83.3%
  • Biochemistry, Genetics and Molecular Biology9.9%
  • Nursing1.9%
  • Engineering1%
  • Health Professions0.7%
  • Computer Science0.7%
  • Other2.5%

Topics

  • Colorectal Cancer Screening and Detection20.9%
  • Gastric Cancer Management and Outcomes7.7%
  • Genetic factors in colorectal cancer6%
  • Global Cancer Incidence and Screening5.9%
  • Colorectal Cancer Surgical Treatments4.6%
  • Microscopic Colitis2.4%
  • Other52.5%

Coauthors

All papers

Open in search
  1. Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 3,152

  2. Prevention of Colorectal Cancer by Colonoscopic Polypectomy

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 1993 cited by 4,594

  3. Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood

    Authors: , , , , , , - New England Journal of Medicine 1993 cited by 3,255

  4. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

    Authors: , , , , , , , , , , , , , , , , - Gastroenterology 2008 cited by 3,007

  5. Long-Term Mortality after Screening for Colorectal Cancer

    Authors: , , , , , , - New England Journal of Medicine 2013 cited by 843

  6. The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer

    Authors: , , , , , , , - New England Journal of Medicine 2000 cited by 1,422

  7. A Randomized Trial of Aspirin to Prevent Colorectal Adenomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2003 cited by 1,425

  8. Use of Colonoscopy to Screen Asymptomatic Adults for Colorectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2000 cited by 1,822

  9. Folic Acid for the Prevention of Colorectal Adenomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2007 cited by 932

  10. A Pooled Analysis of Advanced Colorectal Neoplasia Diagnoses After Colonoscopic Polypectomy

    Authors: , , , , , , , , , , , , , , , - Gastroenterology 2008 cited by 559

  11. Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA -Mutant Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 39

  12. Guidelines for Colonoscopy Surveillance after Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society,

    Authors: , , , , , , , , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2006 cited by 761

  13. Volume, Composition, and Source of Intestinal Gas

    Authors: , - Gastroenterology 1970 cited by 198

  14. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer

    Authors: , , , , , , , , , , , , - The American Journal of Gastroenterology 2002 cited by 1,025

  15. Randomized Comparison of Surveillance Intervals after Colonoscopic Removal of Newly Diagnosed Adenomatous Polyps

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 1993 cited by 974

  16. CIMP Status of Interval Colon Cancers: Another Piece to the Puzzle

    Authors: , , , , , , - The American Journal of Gastroenterology 2009 cited by 389

  17. Safety and activity of single-agent giredestrant (GDC-9545) from a phase Ia/b study in patients (pts) with estrogen receptor-positive (ER+), HER2-negative locally advanced/metastatic breast cancer (LA/mBC).

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 40

  18. Evaluation of pharmacodynamic (PD) and biologic activity in a preoperative window-of-opportunity (WOO) study of giredestrant (GDC-9545) in postmenopausal patients (pts) with estrogen receptor-positive, HER2-negative (ER+/HER2–) operable breast cancer (BC).

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 23

  19. Colorectal Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult Blood

    Authors: , , , - JNCI Journal of the National Cancer Institute 1999 cited by 793

  20. Colorectal Cancer in Patients Under Close Colonoscopic Surveillance

    Authors: , , , , , , , , , , , , , , , , , , , - Gastroenterology 2005 cited by 443

  21. One-Time Screening for Colorectal Cancer with Combined Fecal Occult-Blood Testing and Examination of the Distal Colon

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2001 cited by 584

  22. Quantitative Measurement of Lactose Absorption

    Authors: , - Gastroenterology 1976 cited by 191

  23. A Clinical Trial of Antioxidant Vitamins to Prevent Colorectal Adenoma

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 1994 cited by 769

  24. Five-Year Colon Surveillance After Screening Colonoscopy

    Authors: , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2007 cited by 406